600276.SH
恒瑞医药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 46.76
−2.05%Margins
Gross margin
86.5%
EBITDA margin
30.4%
EBIT margin
29.2%
Net margin
24.9%
FCF margin
26.1%
12.8%
Return on equity
11.4%
Return on assets
14.9%
Return on invested capital
0.46x
Asset turnover
CNY 11.5B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026